Results of cutting-edge surgery in stage IIIA-N2 nonsmall cell lung cancer

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Current Opinion in Oncology

• Publication date

  2009-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/CCO.0b013e3283210476PMID 19532010
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Early surgical results after pneumonectomy for non-small cell lung cancer are not affected by preoperative radiotherapy and chemotherapy.

  2008cited by this paper
• Persistent N2 disease after induction therapy does not jeopardize early and medium term outcomes of pneumonectomy.

  2008cited by this paper
• Survival of patients with unsuspected N2 (stage IIIA) nonsmall-cell lung cancer.

  2008cited by this paper
• The treatment of patients with stage IIIA non-small cell lung cancer from N2 disease: who returns to the surgical arena and who survives.

  2008cited by this paper
• Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer.

  2008cited by this paper
• Complete mediastinal lymphadenectomy: the core component of the multidisciplinary therapy in resectable non-small cell lung cancer.

  2008cited by this paper
• Mortality associated with pneumonectomy after induction chemoradiation versus chemotherapy alone in stage IIIA-N2 non-small cell lung cancer.

  2008cited by this paper
• Prognostic stratification of stage IIIA-N2 non-small-cell lung cancer after induction chemotherapy: a model based on the combination of morphometric-pathologic response in mediastinal nodes and primary tumor response on serial 18-fluoro-2-deoxy-glucose positron emission tomography.

  2008cited by this paper
• Lung cancer staging techniques and induction therapy: maybe timing is everything.

  2008cited by this paper
• Consensus conference: multimodality management of early- and intermediate-stage non-small cell lung cancer.

  2008cited by this paper
• Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer.

  2007cited by this paper
• Operative complications and early mortality after induction therapy for lung cancer.

  2007cited by this paper
• Scalpels, beams, drugs, and dreams: challenges of stage IIIA-N2 non-small-cell lung cancer.

  2007cited by this paper
• Completely resected non-small cell lung cancer: reconsidering prognostic value and significance of N2 metastases.

  2007cited by this paper
• The transcervical extended mediastinal lymphadenectomy versus cervical mediastinoscopy in non-small cell lung cancer staging.

  2007cited by this paper
• Comment on: Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 Non-Small-Cell Lung cancer. Authors' reply

  2007cited by this paper
• Re: Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non small-cell lung cancer.

  2007cited by this paper
• Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small cell lung cancer.

  2007cited by this paper
• Long-term survival associated with complete resection after induction chemotherapy in stage IIIA (N2) and IIIB (T4N0-1) non small-cell lung cancer patients: the Spanish Lung Cancer Group Trial 9901.

  2007cited by this paper
• Treatment of non-small cell lung cancer-stage IIIA: ACCP evidence-based clinical practice guidelines (2nd edition).

  2007cited by this paper
• Re: operative complications and early mortality after induction therapy for lung cancer.

  2007cited by this paper
• Ratio of the maximum standardized uptake value on FDG-PET of the mediastinal (N2) lymph nodes to the primary tumor may be a universal predictor of nodal malignancy in patients with nonsmall-cell lung cancer.

  2007cited by this paper
• ESTS guidelines for preoperative lymph node staging for non-small cell lung cancer.

  2007cited by this paper
• Improved results of induction chemoradiation before surgical intervention for selected patients with stage IIIA-N2 non-small cell lung cancer.

  2007cited by this paper
• Induction chemoradiotherapy (carboplatin-taxane and concurrent 50-Gy radiation) for bulky cN2, N3 non-small cell lung cancer.

  2007cited by this paper
• Prognostic factors affecting long-term outcomes in patients with resected stage IIIA pN2 non-small-cell lung cancer: 5-year follow-up of a phase II study

  2006cited by this paper
• Surgery for non-small cell lung cancer: systematic review and meta-analysis of randomised controlled trials

  2006cited by this paper
• Sampling or node dissection for intraoperative staging of lung cancer: a multicentric cross-sectional study.

  2006cited by this paper
• Pneumonectomy after high-dose radiation and concurrent chemotherapy for nonsmall cell lung cancer.

  2006cited by this paper
• ESTS guidelines for intraoperative lymph node staging in non-small cell lung cancer.

  2006cited by this paper
• Nodal status at repeat mediastinoscopy determines survival in non-small cell lung cancer with mediastinal nodal involvement, treated by induction therapy.

  2006cited by this paper
• Prospective comparative study of integrated positron emission tomography-computed tomography scan compared with remediastinoscopy in the assessment of residual mediastinal lymph node disease after induction chemotherapy for mediastinoscopy-proven stage IIIA-N2 Non-small-cell lung cancer: a Leuven Lu

  2006cited by this paper
• Restaging patients with N2 (stage IIIa) non-small cell lung cancer after neoadjuvant chemoradiotherapy: a prospective study.

  2006cited by this paper
• Results of initial operations in non-small cell lung cancer patients with single-level N2 disease.

  2006cited by this paper
• Selection of patients for surgery after induction chemotherapy for N2 non-small-cell lung cancer.

  2006cited by this paper
• Morbidity and mortality in the surgery arm of EORTC 08941 trial

  2005cited by this paper
• One hundred consecutive pneumonectomies after induction therapy for non-small cell lung cancer: an uncertain balance between risks and benefits.

  2005cited by this paper
• Phase III study of concurrent chemotherapy and radiotherapy (CT/RT) vs CT/RT followed by surgical resection for stage IIIA(pN2) non-small cell lung cancer (NSCLC): Outcomes update of North American Intergroup 0139 (RTOG 9309)

  2005cited by this paper
• Creeping phase II-ism and the medical pharmaceutical complex: weapons of mass distraction in the war against lung cancer.

  2005cited by this paper
• Prolonged survival in patients with resected non-small cell lung cancer and single-level N2 disease.

  2004cited by this paper
• A randomized trial comparing induction chemotherapy followed by surgery with surgery alone for patients with stage IIIA N2 non-small cell lung cancer (JCOG 9209).

  2003cited by this paper
• Survival of patients with resected N2 non-small-cell lung cancer: evidence for a subclassification and implications.

  2000cited by this paper

• Identificación mediante inmunohistoquímica de factores pronósticos biomoleculares en el carcinoma broncogénico no microcítico en estadio precoz resecado

  2014cites this paper
• Carcinoma broncogénico no microcítico resecado, estadio pIIIA-N2. ¿En qué pacientes la adyuvancia ofrece mayor beneficio?

  2014cites this paper
• [Resected non-small cell bronchogenic carcinoma stage pIIIA-N2. Which patients will benefit most from adjuvant therapy?].

  2014cites this paper
• Surgical outcomes after initial surgery for clinical single-station N2 non-small-cell lung cancer.

  2014cites this paper
• Surgical results and survival of older patients with unsuspected N₂ (stage IIIA) non-small cell lung cancer.

  2013cites this paper
• Early and long-term results of pulmonary resection for non-small-cell lung cancer in patients over 75 years of age: a multi-institutional study.

  2013cites this paper
• Induction therapy for lung cancer: sailing across the pillars of Hercules.

  2012cites this paper
• The surgical prognosis of pIIIA/N2 non-small-cell lung cancers

  2011cites this paper
• Lobectomy After Induction Therapy for Stage IIIA NSCLC in the Presence of Persistent N2 Disease

  2011cites this paper
• Does induction treatment increase the risk of morbidity and mortality after pneumonectomy? A multicentre case-matched analysis.

  2010cites this paper
• 不同因素对pⅢa/N2期非小细胞肺癌患者预后的影响

  2010cites this paper